These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36253862)

  • 1. Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors.
    Winiszewski H; Piton G; Capellier G
    Crit Care; 2022 Oct; 26(1):313. PubMed ID: 36253862
    [No Abstract]   [Full Text] [Related]  

  • 2. Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis.
    Moussa MD; Beyls C; Lamer A; Roksic S; Juthier F; Leroy G; Petitgand V; Rousse N; Decoene C; Dupré C; Caus T; Huette P; Guilbart M; Guinot PG; Besserve P; Mahjoub Y; Dupont H; Robin E; Meynier J; Vincentelli A; Abou-Arab O
    Crit Care; 2022 Aug; 26(1):257. PubMed ID: 36028883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.
    Yang L; Ye L; Fan Y; He W; Zong Q; Zhao W; Lin R
    Eur J Pediatr; 2019 Jun; 178(6):783-793. PubMed ID: 30834480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperoxia in patients on venoarterial extracorporeal membrane oxygenation.
    Li C; Wang X; Hou X
    Crit Care; 2022 Oct; 26(1):331. PubMed ID: 36303250
    [No Abstract]   [Full Text] [Related]  

  • 5. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1894-1902.e3. PubMed ID: 30343699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock.
    Vallabhajosyula S; O'Horo JC; Antharam P; Ananthaneni S; Vallabhajosyula S; Stulak JM; Dunlay SM; Holmes DR; Barsness GW
    ASAIO J; 2020 May; 66(5):497-503. PubMed ID: 31335363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study.
    Schrage B; Becher PM; Bernhardt A; Bezerra H; Blankenberg S; Brunner S; Colson P; Cudemus Deseda G; Dabboura S; Eckner D; Eden M; Eitel I; Frank D; Frey N; Funamoto M; Goßling A; Graf T; Hagl C; Kirchhof P; Kupka D; Landmesser U; Lipinski J; Lopes M; Majunke N; Maniuc O; McGrath D; Möbius-Winkler S; Morrow DA; Mourad M; Noel C; Nordbeck P; Orban M; Pappalardo F; Patel SM; Pauschinger M; Pazzanese V; Reichenspurner H; Sandri M; Schulze PC; H G Schwinger R; Sinning JM; Aksoy A; Skurk C; Szczanowicz L; Thiele H; Tietz F; Varshney A; Wechsler L; Westermann D
    Circulation; 2020 Dec; 142(22):2095-2106. PubMed ID: 33032450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Intraaortic Balloon Pumping Under Venoarterial Extracorporeal Membrane Oxygenation on Mortality of Cardiogenic Patients: An Analysis Using a Nationwide Inpatient Database.
    Aso S; Matsui H; Fushimi K; Yasunaga H
    Crit Care Med; 2016 Nov; 44(11):1974-1979. PubMed ID: 27322361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Predictors in Elderly Patients With Cardiogenic Shock on Venoarterial Extracorporeal Life Support. Analysis From the Extracorporeal Life Support Organization Registry.
    Kowalewski M; Zieliński K; Maria Raffa G; Meani P; Lo Coco V; Jiritano F; Fina D; Matteucci M; Chiarini G; Willers A; Simons J; Suwalski P; Gaudino M; Di Mauro M; Maessen J; Lorusso R
    Crit Care Med; 2021 Jan; 49(1):7-18. PubMed ID: 33060505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to Arterial Hyperoxia During Extracorporeal Membrane Oxygenator Support and Mortality in Patients With Cardiogenic Shock.
    Jentzer JC; Miller PE; Alviar C; Yalamuri S; Bohman JK; Tonna JE
    Circ Heart Fail; 2023 Apr; 16(4):e010328. PubMed ID: 36871240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock.
    Patel SM; Lipinski J; Al-Kindi SG; Patel T; Saric P; Li J; Nadeem F; Ladas T; Alaiti A; Phillips A; Medalion B; Deo S; Elgudin Y; Costa MA; Osman MN; Attizzani GF; Oliveira GH; Sareyyupoglu B; Bezerra HG
    ASAIO J; 2019 Jan; 65(1):21-28. PubMed ID: 29489461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoxia in patients with cardiogenic shock after myocardial infarction supported with venoarterial extracorporeal membrane oxygenation.
    Ross P; Miller C; Sheldrake J; McGuiness W; Udy A; Burrell A
    Aust Crit Care; 2021 Jan; 34(1):55-59. PubMed ID: 32620254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of in-hospital mortality in venoarterial extracorporeal membrane oxygenation.
    Vigneshwar NG; Kohtz PD; Lucas MT; Bronsert M; J Weyant M; F Masood M; Itoh A; Rove JY; Reece TB; Cleveland JC; Pal JD; Fullerton DA; Aftab M
    J Card Surg; 2020 Oct; 35(10):2512-2521. PubMed ID: 32789912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest.
    Pineton de Chambrun M; Bréchot N; Lebreton G; Schmidt M; Hekimian G; Demondion P; Trouillet JL; Leprince P; Chastre J; Combes A; Luyt CE
    Intensive Care Med; 2016 Dec; 42(12):1999-2007. PubMed ID: 27681706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of in-hospital mortality in adult postcardiotomy cardiogenic shock patients successfully weaned from venoarterial extracorporeal membrane oxygenation.
    Xie H; Yang F; Hou D; Wang X; Wang L; Wang H; Hou X
    Perfusion; 2020 Jul; 35(5):417-426. PubMed ID: 31854226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    Uemura T
    JAMA; 2022 May; 327(19):1928. PubMed ID: 35579647
    [No Abstract]   [Full Text] [Related]  

  • 17. Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    Pappalardo F; Montisci A
    JAMA; 2022 May; 327(19):1927-1928. PubMed ID: 35579646
    [No Abstract]   [Full Text] [Related]  

  • 18. Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO-Reply.
    Levy B; Combes A; Girerd N
    JAMA; 2022 May; 327(19):1928-1929. PubMed ID: 35579643
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
    Schmidt M; Burrell A; Roberts L; Bailey M; Sheldrake J; Rycus PT; Hodgson C; Scheinkestel C; Cooper DJ; Thiagarajan RR; Brodie D; Pellegrino V; Pilcher D
    Eur Heart J; 2015 Sep; 36(33):2246-56. PubMed ID: 26033984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen Thresholds and Mortality During Extracorporeal Life Support in Adult Patients.
    Munshi L; Kiss A; Cypel M; Keshavjee S; Ferguson ND; Fan E
    Crit Care Med; 2017 Dec; 45(12):1997-2005. PubMed ID: 28787294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.